页数:578 定价:$ 224.87 装帧:HRD ISBN:9781588298706 豆瓣评分 目前无人评价 评价: 内容简介· ··· This volume represents a compendium of scientific findings and approaches to the study of angiogenesis in cancer. The second edition of Antiangiogenic Agents in Cancer Therapy is intended to give a...
The specific carcinogenesis explains that anti-angiogenic agents have double targets in this tumor: the endothelial cells of the neo-vascularization as well as tumor cells. In conclusion, the development of effective anti-angiogenic treatment for advanced renal cancer was responsible for a substantial ...
With the role of angiogenesis in tumor growth and progression firmly established, considerable effort has been directed to antiangiogenic therapy as a new modality to treat human cancers. Antiangiogenic agents have recently received much widespread atten
Antiangiogenic Agents in Cancer Therapy Totowa, NJ: Humana Press, 1999. Periodicals Frankish, Helen. "Researchers Target Tumour Blood Vessels With Antiangiogenic Gene Therapy." The Lancet (June 29, 2002): 2256. Guttman, Cheryl. "Anti-Angiogenic Therapy Explored for Retinoblastoma." Ophthalmology ...
Current Opinion in BiotechnologyKlohs, WD, Hamby, JM (1999) Antiangiogenic agents. Curr Opin Biotechnol 10: pp. 544-549Deplanque G, Harris AL: Anti-angiogenic agents: clinical trial design and therapies in development. Eur J Cancer 36:1713–24, 2000...
In many cases combination therapy with an anti-angiogenic substance together with radiation, chemotherapy or other types of conventional treatment, appears promising. 展开 关键词: Animals Humans Metalloendopeptidases Fibroblast Growth Factors Antineoplastic Agents Receptors, Growth Factor Tomography, Emission-...
Development of Vascular Endothelial Growth Factor Receptor (VEGFR) Kinase Inhibitors as Anti-Angiogenic Agents in Cancer Therapy " Development of Vascular Endothelial Growth Factor Receptor (VEGFR) Kinase Inhibitors as Anti- Angiogenic Agents in Cancer Therapy, " Current Medicinal Chemis... TL Under...
Modification of the Bascom cleft lift procedure for chronic pilonidal sinus: results in 141 patients. Colorectal Dis. 2013;15:e402–6.Gadducci A, Sergiampietri C, Guiggi I (2013) Antiangiogenic agents in advanced, persistent or recurrent endometrial cancer: a novel treatment option. Gynecol ...
However, antiangiogenic agents have achieved limited success as monotherapies. This may be in part because the ... D Lazarus,C Peters,K Deotale,... - 《Cancer Research》 被引量: 0发表: 2013年 Challenges of antiangiogenic cancer therapy: trials and errors, and renewed hope Medina MA, ...
Angiogenesis is one of the hallmarks of cancer and plays a crucial role in carcinogenesis and progression of epithelial ovarian cancer. Antiangiogenic agent is the first approved targeted agent in ovarian cancer. Anti-angiogenic agents mainly include agents target VEGF/VEGFR pathway, such as bevacizuma...